# EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients

> **NCT05188573** · NA · WITHDRAWN · sponsor: **ClearNote Health**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** Early detection pancreatic cancer test
- **DEVICE:** Early detection pancreatic cancer test and MRI Imaging

## Key facts

- **NCT ID:** NCT05188573
- **Lead sponsor:** ClearNote Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not initiated.
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188573, "EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05188573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*